# OnCo record staging-systems (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/staging-systems/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "staging-systems" ;
  schema:name "Disease-specific staging and risk systems (FIGO, Ann Arbor, IPI, R-ISS, ELN, IMDC)"@en ;
  schema:alternateName "FIGO"@en, "FIGO stage"@en, "AJCC"@en, "AJCC 8th edition"@en, "UICC"@en, "Ann Arbor"@en, "Ann Arbor staging"@en, "R-ISS"@en, "R2-ISS"@en, "ISS stage"@en, "ELN 2022"@en, "ELN risk"@en, "IMDC"@en, "IMDC risk"@en, "Heng criteria"@en, "INRG"@en, "COG risk group"@en, "Rai stage"@en, "Binet stage"@en, "Masaoka"@en, "Enneking"@en, "risk group"@en, "risk-group"@en, "risk stratification"@en, "risk-stratified"@en, "prognostic index"@en, "prognostic score"@en, "nomogram"@en ;
  schema:description "Beyond the generic TNM system, gynaecological cancers (FIGO), lymphoma (Ann Arbor, IPI), myeloma (R-ISS), AML (ELN), kidney cancer (IMDC), neuroblastoma (INRG) and CLL (Rai, Binet) each have their own system that combines stage, blood tests, genetics and fitness into risk groups. The name on the report tells you which rulebook sets the treatment intensity."@en ;
  schema:url <https://onco.cc/terms/staging-systems/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_staging> ;
  schema:citation <https://en.wikipedia.org/wiki/Cancer_staging> ;
  onco:related <https://onco.cc/terms/tnm-staging/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/bclc-staging/>, <https://onco.cc/terms/cytogenetics/>, <https://onco.cc/terms/performance-status/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> .
